Diabetes News

Sequel’s twiist Automated Insulin Delivery System Receives FDA Clearance

The twiist Automated Insulin Delivery System Receives FDA Clearance

On March 18, 2024, Sequel Med Tech announced that its partner—DEKA Research & Development Corp.—received FDA clearance for the twiist Automated Insulin Delivery (AID) system. Using the FDA-cle...MORE
Dexcom Introduces Direct-to-Apple-Watch Feature for its G7 CGM

Dexcom Introduces Direct-to-Apple-Watch Feature for its G7 CGM

Dexcom recently introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users. This means G7 will be the only CGM system that can connect directly to Apple Watch without...MORE
Payment Assistance and Savings Program Extended for the Eversense E3 CGM

Payment Assistance and Savings Program Extended for the Eversense E3 CGM

Ascensia Diabetes Care and Senseonics have extended their Eversense Payment Assistance and Simple Savings (PASS) program—aimed to help people in the U.S. more affordably access the Eversense E3 cont...MORE
The Tandem Mobi is Now Available

The Tandem Mobi is Now Available

World’s Smallest Automated Insulin Delivery System Lets People With Diabetes Experience the Benefits of Control-IQ TechnologyMORE
t:slim X2 Becomes First Automated-Insulin-Delivery System to Fully Integrate With the FreeStyle Libre 2 Plus CGM

t:slim X2 Becomes First Automated-Insulin-Delivery System to Fully Integrate With the FreeStyle Libre 2 Plus CGM

t:slim X2 becomes first automated-insulin-delivery system to fully integrate with the FreeStyle Libre 2 Plus continuous glucose monitoring system MORE

ADA Standards of Care 2024: So What’s New?

Diabetes research, technology, and treatments are rapidly changing. Here's what you need to know about the 2024 Standards of Care.MORE

Dexcom G7 Now Integrated with T:slim X2

Tandem’s T:slim X2 insulin pump is the first automated insulin delivery system to fully integrate with Dexcom’s G7 continuous glucose monitoring system.MORE

Benefits of Using a Dexcom G7 CGM During Pregnancy

Managing diabetes during pregnancy can be tough, but Dexcom Chief Operating Officer Jake Leach shares how a CGM can help.MORE

GoodRx Announces New Way for People to Access Lantus for $35

GoodRx partnered with Sanofi to offer $35 insulin coupons to all, regardless of their insurance status, for use at pharmacies nationwide. MORE

New Program Recognizes Leaders In Diabetes Care

Received stellar diabetes care? Encourage your providers to apply to be recognized as leaders in diabetes care.MORE

Vertex VX-880 Clinical Results Lead To Insulin-Independence

Here's what you need to know about Vertex's recent results from their stem-cell therapy for type 1 diabetes.MORE

Ketogenic Diet for Kids with Diabetes Carries Risk

The American Academy of Pediatrics warns against a ketogenic diet, a popular low-carbohydrate diet, for children with diabetes.MORE

Dexcom ONE Now Available in France

Dexcom ONE, a continuous glucose monitoring (CGM) system, is now available for people with diabetes in France.MORE

Beyond Type 2 Expands to Provide Resources to Canada

Canadians can now share their stories, get connected to the community and find critical resources on all things type 2 diabetes. MORE

New Pfizer Vaccine Available Fall 2023

The new COVID vaccine shot will soon be available for fall. This article will detail everything you need to know to protect yourself.MORE

How You Can Try a Dexcom CGM for Free

Learn why continuous glucose monitors (CGMs) are beneficial and how you can try the free 10-day Dexcom trial program.MORE

T1D Clinical Trial Search Engine Now Available In Spanish

Beyond Type 1 collaborates with Antidote Technologies and JDRF to launch the first-ever Spanish-language clinical trial search engine for type 1 diabetes.MORE

Project IMPACT: Bringing CGM Access to a Pharmacy Near You

Interview with Robert E. Nichols, PharmD, BCPS, Clinical Pharmacist, who is participating in the pilot program for better CGM access. MORE

Beyond Type Run Marathon Team Reaches New Milestones in 2023

Beyond Type Run, the stereotype-smashing team of runners proves anybody living with diabetes can go the distance despite their diagnosis.MORE

Moms’ Night Out Aims to Support Caregivers of People with Type 1 Diabetes

“Moms’ Night Out” expands after exciting launch. Attend an upcoming event for mothers of children with diabetes in these three cities!MORE

JDRF’s Children’s Congress: Finding A Cure For Type 1 Diabetes

Learn more about JDRF, its mission behind the biannual Children’s Congress and the impact of this year's event.MORE

Tandem’s Mobi Approved by the FDA

Tandem’s newest insulin pump, Mobi, was approved by the FDA for people with diabetes age six and up. Here's what you need to know!MORE

A Year in Review: Advancements in Diabetes Tech + Research

This session reviewed the advances and discoveries in research and technology for people living with diabetes over the past year.MORE

Senseonics + UnitedHealthcare Expanding CGM Access

Senseonics announced that UnitedHealthCare will now cover their Eversense E3 implantable CGM, starting July 1, 2023.MORE
Medtronic 780G Receives FDA Approval

Medtronic’s MiniMed 780G Receives FDA Approval 

The FDA has approved Medtronic’s MiniMed 780G, the newest automated insulin dosing (AID) system on the market. MORE
Baqsimi acquired

Eli Lilly’s Baqsimi Acquired by Amphastar: What This Means for People With Diabetes

Eli Lilly’s nasal glucagon, Baqsimi, has been acquired by Amphastar. Here’s what you should know about the change and its significance.MORE

Mark Cuban’s Cost Plus Drugs Makes Diabetes Products More Affordable

Mark Cuban's Cost Plus Drugs Company just announced that they offer Janssen's Invokana, Invokamet and Invokamet XR for type 2 diabetes.MORE

Why Diabetes Should be Screened by Age Instead of Weight

Many cases of diabetes may be missed by screening only by weight instead of age, especially for some racial and ethnic groups.MORE

California Partners with Civica Rx to Make More Affordable Insulin 

California has signed a contract with Civica Rx to make more affordable insulin for Americans with diabetes. Here’s what you should know about their partnership, CalRx.MORE

Sanofi to Slash Price of Lantus by 78%, Cap Out-of-Pocket Costs to $35

Sanofi has capped monthly out-of-pocket costs for Lantus to $35 for all with commercial insurance and will cut the price of Lantus by 78%, effective January 1, 2024. MORE

Novo Nordisk to Slash Insulin Prices by over 65%

Novo Nordisk announced that starting January 1st, 2024 they will be lowering the list price of several of their insulins by 65-70%.MORE
Freestyle Libre 2 and Freestyle Libre 3 to Integrate with Automated Insulin Delivery Systems

Freestyle Libre 2 and Freestyle Libre 3 to Integrate with Automated Insulin Delivery Systems

Abbott, makers of the Freestyle Libre 2 and 3, modified their sensors to enable integration with automated insulin delivery systems. Here’s what you should know!MORE

$25 List Price + $35 Copay Caps: Lilly’s New Insulin Cost Reductions

On March 1, 2023, insulin manufacturer Lilly announced expanded insulin cost-saving measures for people with and without health insurance coverage.MORE

FDA Approves Teplizumab to Delay Onset of Type 1 Diabetes

Teplizumab binds to certain immune system cells and delays the progression of T1D.MORE

This New App is Designed to Make Tracking Your Insulin Easier

If you use Lilly brand insulin, this new connected platform is designed to make tracking your diabetes data a lot easier. MORE

Say Hello to BeyondType2.org in French, German and Italian!

BeyondType2.org now offers critical resources in five languages for people living with and impacted by type 2 diabetes.MORE

The Future of Insulin — Will It Be Affordable for the People Who Need It?

Research is showing promising advancements with new weekly oral and injectable insulins—but will they actually be affordable?MORE

Diabetes + Dementia: Using Nasal Insulin to Improve Brain Function

With rising rates of obesity in both type 1 and type 2 diabetes, understanding the impact on long-term brain health and function is critical.MORE

Women + Exercise: It’s Complicated

Women living with type 1 diabetes are told exercise will help better manage their diabetes. That’s easier said than done. MORE

Reaching Everyone — Health Disparities in Physical Activity

People living with diabetes are told to just exercise more to better manage their diabetes. Here is why its not that simple. MORE

Another Reminder that Racial/Ethnic Inequality Exists in Diabetes Care

Despite the variety of diabetes medications and technology, race and ethnicity still weigh heavily on a person’s access to these life-saving tools.MORE

Race, Racism, and Diabetes Research

Diabetes care and research is still drastically impacted by racist practices. It’s time to call the racism out. MORE

Mounjaro: Its Powerful Potential to Treat Type 2 Diabetes & Obesity

Experts discuss the impressive impact and future potential of using Mounjaro (tirzepatide) to treat obesity and type 2 diabetes.MORE

Research: Practical Use of Closed-Loop Insulin Pumps

Closed-loop insulin pump technology is a game-changer for those taking insulin. Here are essential tips to using them in day-to-day life.MORE

Access to Insulin: In the United States

Despite the growing variety of insulin and technology, access to this life-saving drug continues to be a dire problem in the United States.MORE

Access to Insulin: In Low-Income Countries

In many countries, a person with diabetes may walk for four days to get a vial of short-acting insulin and seven to 10 days for long-acting.MORE
tirzepatide weight loss research

Promising New Drug Leads to 22.5% Weight Loss in Adults Living with Obesity

The latest study on a new drug is making headlines for its impressive ability to help patients lose weight.MORE

Stem Cell Therapy for Type 1 Diabetes: Patient Achieved Insulin Independence on Day 270

A patient in the Vertex Pharmaceutical’s clinical trial using stem-cell therapy to treat type 1 diabetes has achieved insulin independence on Day 270 of the trial. MORE

Coverage of Dexcom G6 CGM Now Improved with TRICARE

TRICARE healthcare members can now receive the Dexcom G6 continuous glucose monitor (CGM) under pharmacy benefits.MORE
insulin copays

The Affordable Insulin Now Act: A Step Toward Federal Legislation

The Affordable Insulin Now Act, if passed in its current form, could help bring down the cost of insulin for millions of insured people with diabetes.MORE

FreeStyle Libre 2 Now More Easily Accessible for Military Members Through TRICARE

Military members with TRICARE now have easier access to Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM).MORE
Dexcom Breakthrough Device Designation

COVID-19 Pushes FDA Approval of Breakthrough Device Designation for Dexcom CGM in Hospital Settings

The FDA has granted Breakthrough Device Designation for Dexcom CGM in hospital settings after the pandemic highlighted essential care needs for patients with diabetes.MORE
Eversense E3

Eversense E3 Continuous Glucose Monitor Gains FDA Approval, Offers Extended Wear-Time

The Eversense E3 continuous glucose monitor (CGM) is an exciting advancement for the diabetes community, with improved wear-time and accuracy.MORE

Omnipod 5 Receives FDA Approval

Omnipod 5, a closed-loop tubeless insulin pump with smartphone control that integrates with the Dexcom G6 continuous glucose monitor, has now received FDA approval.MORE
Drug Pricing Investigation

Inside the Drug Pricing Investigation from the House Oversight and Reform Committee

The results of the most recent report from the committee make things clear for the United States — the need for access to affordable healthcare is direr than ever.MORE

The Potential Impact of Build Back Better on American Healthcare

Dive into the basics of Build Back Better, why people with diabetes should follow the bill as it progresses, and the impact it could have on your health.MORE
Mark Cuban Pharmacy

Mark Cuban’s New Online Pharmacy Provides Affordable Access to Some Common Prescription Drugs

Mark Cuban's latest investment in the pharmaceutical industry offers common generic prescription medications (not including insulin) at a fraction of the cost.MORE

A Win for T1D in California: Senate Bill 97 Signed Into Law

The bill requires type 1 diabetes informational materials to be developed for the parents and guardians of pupils in California schools.MORE

Beyond Type 1 Launches Web Platform in Arabic 

Diabetes information, stories, and news are now available in Arabic at ar.beyondtype1.org.MORE

COVID-19 Vaccines For Kids Ages 5 to 11 With Diabetes: What to Know

COVID-19 vaccines are now available for kids age 5+! Learn about safety and managing side effects for kids with type 1 diabetes.MORE
vertex pharmaceuticals stem cell therapy for type 1 diabetes

Stem-Cell Therapy for Type 1 Diabetes Reduced Patient’s Insulin Needs by 91%

The early results of a clinical trial using stem-cell therapy to treat type 1 diabetes reduced the patient’s insulin needs by 91%.MORE

Lilly Announces Lower List price for Insulin Lispro

The company will lower the list price of the generic version of Humalog in the U.S. by an additional 40 percent starting January 1, 2022.MORE

Lilly Issues Voluntary Nationwide Recall of One Lot of Glucagon Emergency Kit

Lilly announced the voluntary recall of lot D239382D, Expiration April 2022 of Glucagon Emergency Kits.MORE
Latinx Diabetes Initiative

The Latinx Diabetes Initiative Provides Culturally Tailored Care To Latinx Patients With Diabetes

Andreina Millan Ferro is centering culturally sensitive diabetes care for Latinx patients with diabetes at the Latinx Diabetes Initiative.MORE
Yarishdy Mora

Yarishdy Mora Is Empowering Youth Through Diabetes Education In Mexico

Yarishdy Mora is the director of the Youth Health Program for Project HOPE in Mexico. She creates platforms that help youth learn about diabetes. MORE
Screened for Type 2 Diabetes

Overweight Adults to Now Be Screened for Type 2 Diabetes At 35

The U.S. Preventive Services Task Force now recommends overweight and obese adults to get screened for Type 2 diabetes at the age of 35.MORE
pandemic homelessness

Pandemic Homelessness Disproportionately Impacts People With Diabetes

An American Diabetes Association report found that pandemic homelessness hit people with diabetes 48 times harder.MORE
Freestyle Libre 2

Abbott’s FreeStyle Libre 2 App Receives FDA Clearance

On August 2, 2021, the FDA approved the FreeStyle Libre 2 app for adults and children with diabetes, allowing user to access glucose readings directly from their iPhone.MORE

FDA Approves Senza®, Nevro’s High Frequency Spinal Cord Stimulation Therapy For PDN

The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy.MORE

Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin

Semglee becomes the first interchangeable biosimilar insulin product for the treatment of type 1 and type 2 diabetes.MORE
Culturally Sensitive LGBTQ+ Diabetes Health Care

Providing Culturally Sensitive LGBTQ+ Diabetes Health Care

Culturally sensitive LGBTQ+ diabetes health care can decrease stigma and advance diabetes care access for the LGBTQ community. MORE
Black Mother With Type 1 Diabetes

High Risk Pregnancy – Mitigating Risks for Type 1 Diabetes + Black Maternal Health Outcomes

Ariel Lawrence, a diabetes advocate and Black mother with type 1 diabetes, shares how she navigated her pregnancy. MORE
disparities in pediatric diabetes

Addressing Disparities in Pediatric Diabetes Treatment In Philadelphia

Terri Lipman shares how incorporating community health workers can tackle disparities in pediatric diabetes treatment. MORE

FDA Issues CRL for Teplizumab, Investigational Candidate to Delay the Onset of T1D

The FDA issues a complete response letter to Provention Bio as part of an update for Teplizumab to delay the onset of type 1 diabetes.MORE

Combating Diabetes Disparities Among The Hispanic Population

At ADA 2021, David Marrero discusses how culturally tailored care can combat diabetes disparities among the Hispanic population.MORE

Walmart Launches Lower-Cost Analog Insulin: ReliOn NovoLog

ReliOn NovoLog will be available at Walmart and Sam's Club pharmacies for $72.88 per vial and $85.88 per box of five FlexPens.MORE
depression among african american

Preliminary Findings On Depression Among African American and Latino Parents of Children With T1D

Samantha Carreon shares preliminary data on the TEAM study which found higher rates of depression among African American and Latino parents.MORE
JP Qualters

Making Broadway More Accessible With JP Qualters

JP Qualters shares his experience on Broadway as a person living with type 1 diabetes and his aspirations for the theater industry.MORE

Zegalogue® Is Now Commercially Available In The United States

Zegalogue®, also known as dasiglucagon, is now commercially available in the U.S. for the treatment of severe hypoglycemia.MORE
continuous glucose monitor coverage

Medicare Loosens Restrictions on Continuous Glucose Monitor Coverage

Medicare revised its local coverage determination policy to remove requirements for continuous glucose monitor coverage.MORE
ACA intact

Supreme Court Votes To Keep The ACA Intact

The Affordable Care Act (ACA) provides health care to millions of Americans. The Supreme Court voted 7-2 to keep the ACA intact.MORE
vaccine access

COVID-19 Vaccines And Diabetes: Vaccine Access Issues For People Of Color

Communities of color with diabetes face a myriad of barriers when it comes to vaccine access. Experts share how the U.S. can achieve vaccine equity.MORE
diabetes program accessibility

Michelle L. Litchman Focuses On Diabetes Program Accessibility For People Who Are Deaf

Michelle L. Litchman was named a Betty Irene Moore Nurse Fellow. She will focus on diabetes program accessibility for people who are deaf.MORE

Test Strip Subscription Guide

We compiled a rundown of popular companies that offer test strip subscription services and researched each of them to give you some important info.MORE
omnipod 5

Omnipod 5 Pivotal Trial Data Published

Data from the pivotal trial shows that the Omnipod 5 improves time-in-range, and reduces HbA1c and mean glucose levels. MORE
ATTD 2021

Breaking News From ATTD 2021

This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.MORE
mental health

Survey Finds the Pandemic Increased Mental Health Concerns Among People With Diabetes

Cecelia Health conducted a survey that revealed increased mental health concerns among people with diabetes during the COVID-19 pandemic. MORE

FDA Advisory Committee Votes 10-7 To Recommend Approval of Teplizumab For Delay Of Type 1 Diabetes

Teplizumab is an investigational candidate proven to delay the onset of type 1 diabetes. The FDA advisory committee reviews its efficacy.MORE

Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace

Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.MORE
Bigfoot Unity

Bigfoot Unity™ Diabetes Management System Receives The Green Light From The FDA

Bigfoot Unity™, a one-of-a-kind diabetes management system with smart pen caps received FDA approval on May 10, 2021 and will reach select diabetes clinics this spring. MORE

Asian Isn’t A Monolith: Why More Specific Data Matters in Diabetes Research

Data on how diabetes impacts specific ethnic groups could help us better support people within Asian American Pacific Islander communities.MORE

Type 1 Diabetes + Ramadan: Here’s How a Few People Are Observing

People with diabetes face their own set of challenges when observing Ramadan. Two people with diabetes share their experiences. MORE

The PROTECT Study 

The PROTECT Study aims to understand how the investigational medicine, teplizumab, works in children and young adults who have recently been diagnosed with T1D, as well as assessing if there are any s...MORE
aapi diabetes research

Chris Hahm’s Uphill Battle: The Severe Underfunding of AAPI Diabetes Research

H. Chris Hahm shares her challenges of conducting diabetes research focused on the AAPI community, research that is severely underfunded.MORE

CDC and FDA Call for Pause on Johnson & Johnson Vaccine

After six cases of rare blood clots, the CDC and FDA has advised healthcare professionals to pause on distributing the Johnson and Johnson vaccine.MORE

FDA Approves New Glucagon Option from Zealand Pharma

Available in June 2021, the FDA approved Zealand Pharma’s Zeagalogue, a new form of glucagon for people with insulin-dependent diabetes.MORE
ADA Collab

Two Pillars in the Diabetes Community Unite to Serve Millions Living with Diabetes

The partnership will feature combined resources, strategies, and tactics to better serve people living with type 1 diabetes, type 2 diabetes, and prediabetes.MORE

JDRF Announces New Center of Excellence to Advance T1D Research

On February 23, 2021, JDRF announced the launch of the JDRF Center of Excellence in collaboration with the Harvard Stem Cell Institute in New England.MORE

Get the Facts on Insulin Pricing + The Presidential Transition

A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin. MORE

New Year, New Administration: What’s Coming For US Healthcare Policy

With a new governmental administration, it is likely we will see notable and impactful movement in healthcare policy. What can we expect? MORE